my chart analysis, page-65

Can understand your sentiment mkabk.

This is an infant with a clear case of 'failure to thrive'.

If they do a CR and offer a 20% discount to sophs we will be hammered to blazes.

To be honest, I'm treating this as next year's capital gains write down. If it has a recovery well and good, but if not, it has been a painful experience - not the end of the world.

I sincerely hope that there will be some news this month that will turn this around, but going by the past few months it seems a bit unlikely.

Cheers,

TM.